BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 15874923)

  • 1. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial.
    Brady AR; Gibbs JS; Greenhalgh RM; Powell JT; Sydes MR;
    J Vasc Surg; 2005 Apr; 41(4):602-9. PubMed ID: 15874923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial.
    Yang H; Raymer K; Butler R; Parlow J; Roberts R
    Am Heart J; 2006 Nov; 152(5):983-90. PubMed ID: 17070177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
    Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
    Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.
    Zaugg M; Bestmann L; Wacker J; Lucchinetti E; Boltres A; Schulz C; Hersberger M; Kälin G; Furrer L; Hofer C; Blumenthal S; Müller A; Zollinger A; Spahn DR; Borgeat A
    Anesthesiology; 2007 Jul; 107(1):33-44. PubMed ID: 17585213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study.
    Connolly SJ; Cybulsky I; Lamy A; Roberts RS; O'brien B; Carroll S; Crystal E; Thorpe KE; Gent M;
    Am Heart J; 2003 Feb; 145(2):226-32. PubMed ID: 12595838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.
    ; Devereaux PJ; Yang H; Guyatt GH; Leslie K; Villar JC; Monteri VM; Choi P; Giles JW; Yusuf S
    Am Heart J; 2006 Aug; 152(2):223-30. PubMed ID: 16875901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regarding "Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial".
    Schouten O; van Urk H; Feringa HH; Bax JJ; Poldermans D
    J Vasc Surg; 2005 Oct; 42(4):825; author reply 826. PubMed ID: 16242583
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial.
    Durazzo AE; Machado FS; Ikeoka DT; De Bernoche C; Monachini MC; Puech-Leão P; Caramelli B
    J Vasc Surg; 2004 May; 39(5):967-75; discussion 975-6. PubMed ID: 15111846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial.
    Juul AB; Wetterslev J; Gluud C; Kofoed-Enevoldsen A; Jensen G; Callesen T; Nørgaard P; Fruergaard K; Bestle M; Vedelsdal R; Miran A; Jacobsen J; Roed J; Mortensen MB; Jørgensen L; Jørgensen J; Rovsing ML; Petersen PL; Pott F; Haas M; Albret R; Nielsen LL; Johansson G; Stjernholm P; Mølgaard Y; Foss NB; Elkjaer J; Dehlie B; Boysen K; Zaric D; Munksgaard A; Madsen JB; Øberg B; Khanykin B; Blemmer T; Yndgaard S; Perko G; Wang LP; Winkel P; Hilden J; Jensen P; Salas N;
    BMJ; 2006 Jun; 332(7556):1482. PubMed ID: 16793810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin and perioperative events in patients undergoing vascular surgery.
    Schouten O; Boersma E; Hoeks SE; Benner R; van Urk H; van Sambeek MR; Verhagen HJ; Khan NA; Dunkelgrun M; Bax JJ; Poldermans D;
    N Engl J Med; 2009 Sep; 361(10):980-9. PubMed ID: 19726772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery.
    Ward RP; Leeper NJ; Kirkpatrick JN; Lang RM; Sorrentino MJ; Williams KA
    Int J Cardiol; 2005 Oct; 104(3):264-8. PubMed ID: 16186054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of metoprolol on perioperative cardiovascular events in patients with risk or at high risk for coronary artery disease undergoing non-cardiac surgery].
    Yang XY; Wu XM; Wang S; Wang Q
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1476-80. PubMed ID: 18953854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group.
    Eur Heart J; 1995 Dec; 16(12):1825-32. PubMed ID: 8682014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.
    Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Gentile G; Reboldi G
    Am J Cardiovasc Drugs; 2010; 10(4):247-59. PubMed ID: 20653331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery.
    Halonen J; Hakala T; Auvinen T; Karjalainen J; Turpeinen A; Uusaro A; Halonen P; Hartikainen J; Hippeläinen M
    Circulation; 2006 Jul; 114(1 Suppl):I1-4. PubMed ID: 16820555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery.
    Mostafaie K; Bedenis R; Harrington D
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006342. PubMed ID: 25879091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.
    ; Devereaux PJ; Yang H; Yusuf S; Guyatt G; Leslie K; Villar JC; Xavier D; Chrolavicius S; Greenspan L; Pogue J; Pais P; Liu L; Xu S; Málaga G; Avezum A; Chan M; Montori VM; Jacka M; Choi P
    Lancet; 2008 May; 371(9627):1839-47. PubMed ID: 18479744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAR VaS--Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery.
    Neilipovitz DT; Bryson GL; Taljaard M
    Can J Anaesth; 2012 Jun; 59(6):527-37. PubMed ID: 22528165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.
    Mangano DT; Layug EL; Wallace A; Tateo I
    N Engl J Med; 1996 Dec; 335(23):1713-20. PubMed ID: 8929262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.